The Canadian Cervical Cancer Screening Trial of human papillomavirus (HPV) testing versus Pap cytology
- Conditions
- High-grade cervical intra-epithelial neoplasiaCancerCervical
- Registration Number
- ISRCTN57612064
- Lead Sponsor
- McGill University (Canada) - Research Grants Office
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 10154
Current inclusion criteria as of 05/01/2010:
1. Women aged 30 to 69 years
2. Sought screening tests for cervical cancer in any of 30 family practice or gynaecology clinics in Montreal and St. John's, Canada
Initial inclusion criteria at time of registration:
1. Women aged between 30 and 69 years
2. Currently attending a colposcopy clinic for evaluation, treatment or follow up of a cervical lesion
Current exclusion criteria as of 05/01/2010:
1. Currently being followed up for a cervical lesion
2. Lacked a cervix
3. Pregnant
4. Had a history of cervical cancer
5. Had undergone Pap testing in the previous year
6. Unable to provide consent were excluded (note that this is related also to the ability to understand French or English)
Initial exclusion criteria at time of registration:
1. Without a cervix
2. Pregnant
3. History of cervical cancer
4. Known human immunodeficiency virus (HIV) infection
5. Mentally incompetent
6. Unable to understand French or English
7. Refuse to provide an informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method